Drug Profile
Research programme: replacement therapeutics - Glycomine
Alternative Names: M1P; Mannose-1-phosphate; PMM2-CDG; Recombinant human N-glycanase 1; rhNgly1Latest Information Update: 25 Oct 2021
Price :
$50
*
At a glance
- Originator Glycomine
- Class Enzymes; Sugar phosphates
- Mechanism of Action Enzyme replacements; Mannose replacements
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Congenital disorder of glycosylation type 1A
- No development reported Inborn error metabolic disorders
Most Recent Events
- 23 Jun 2021 Preclinical trials in Congenital disorder of glycosylation type 1A in USA (unspecified route)
- 28 Dec 2020 No recent reports of development identified for early research in Inborn-error-metabolic-disorders in USA
- 16 Nov 2016 Early research in Inborn error metabolic disorders in USA (unspecified route)